Global Anticoagulants Drug Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Report code: BMRC150 | Report Format: | 15-Feb-2018 | Number of pages: 114 | Post Publisher:BEMRC

The report studies and describes the Anticoagulants Drug market in terms of volume and value. The market volume is provided in terms of thousand units; whereas the value for the market is provided in terms of USD million from 2018-2024. The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Anticoagulants Drug market.
This global Anticoagulants Drug market report covers top players like,
• Bayer AG
• Novartis AG
• GlaxoSmithKline plc
• Bristol Myers Squibb Company
• Sanofi
• Boehringer Ingelheim GmbH
• Genentech, Inc.
• AstraZeneca plc
• Others
Global Anticoagulants Drug Market by Product Type
• Coumarins & Indandiones
• factor Xa inhibitors
• Heparins
• thrombin inhibitors
Global Anticoagulants Drug Market by Application
• Atrial fibrillation
• Deep vein thrombosis
• Artificial heart valve
• Pulmonary embolism
• Prevention of blood clots
• Heart attack
Global Anticoagulants Drug Market by Region
• North America
o U.S.
o Mexico
• Europe
o UK
o France
o Germany
• Asia Pacific
o China
o Japan
o India
• Latin America
o Brazil
• The Middle East and Africa

Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. USP’s of Report
1.5. Report Description
2. Chapter – Introduction
2.1. Executive Summary
2.2. Market Drivers
2.3. Market Restraints
2.4. Market Opportunity
3. Chapter – Executive Summary
3.1. Global Anticoagulants Drug Market, 2014 – 2024, (USD Billion)
3.2. Anticoagulants Drug Market snapshot
4. Chapter – Anticoagulants Drug Market: Market Analysis
4.1. Anticoagulants Drug Market Dynamics
4.2. Porter’s Five Forces Analysis
4.3. Market Attractiveness Analysis
4.3.1. Market attractiveness analysis by Drug Class segment
4.3.2. Market attractiveness analysis by Application segment
4.3.3. Market attractiveness analysis by Route Of Administration segment
4.3.4. Market attractiveness analysis by End User segment
4.3.5. Market attractiveness analysis by regional segment
5. Chapter – Global Anticoagulants Drug Market: Global Summary
5.1. Global Anticoagulants Drug Market Production (K Unit) and Growth Rate (%), 2014- 2024
5.2. Global Anticoagulants Drug Market Consumption (K Unit) and Growth (%) Rate, 2014- 2024
5.3. Global Anticoagulants Drug Market Revenue (USD Million) and Growth Rate (%), 2014- 2024
5.4. Global Anticoagulants Drug Market Share (%) by Region, 2014 – 2024
5.5. Global Anticoagulants Drug Market Share (%) by Manufacturer, 2017
5.6. Recent Developments
6. Chapter – Global Anticoagulants Drug Market: By Drug Class
6.1. Global Anticoagulants Drug Market Share (%), by Drug Class, 2014
6.2. Global Anticoagulants Drug Market Share (%), by Drug Class, 2017
6.3. Global Anticoagulants Drug Market Share (%), by Drug Class, 2024
6.4. Global Anticoagulants Drug Market Share (%), by Drug Class, 2017 – 2024
6.5. Global Anticoagulants Drug Market Revenue (USD Million), by Drug Class, 2014 – 2024
6.6. Global Anticoagulants Drug Market Production (K Unit), by Drug Class, 2014 – 2024
6.7. Global Anticoagulants Drug Market Consumption (K Unit), Type, 2014 – 2024
6.8. Global Anticoagulants Drug Market Price (USD/Unit), by Drug Class, 2014 – 2024
6.9. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Drug Class, 2014 – 2024
7. Chapter – Global Anticoagulants Drug Market: Application Analysis
7.1. Global Anticoagulants Drug Market Share (%), by Application, 2014
7.2. Global Anticoagulants Drug Market Share (%), by Application, 2017
7.3. Global Anticoagulants Drug Market Share (%), by Application, 2024
7.4. Global Anticoagulants Drug Market Share (%), by Application, 2017 – 2024
7.5. Global Anticoagulants Drug Market Revenue (USD Million), by Application, 2014 – 2024
7.6. Global Anticoagulants Drug Market Production (K Unit), by Application, 2014 – 2024
7.7. Global Anticoagulants Drug Market Consumption (K Unit), Application, 2014 – 2024
7.8. Global Anticoagulants Drug Market Price (USD/Unit), by Application, 2014 – 2024
7.9. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Application, 2014 – 2024
8. Chapter – Global Anticoagulants Drug Market: Route of Administration Analysis
8.1. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2014
8.2. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2017
8.3. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2024
8.4. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2017 – 2024
8.5. Global Anticoagulants Drug Market Revenue (USD Million), by Route of Administration, 2014 – 2024
8.6. Global Anticoagulants Drug Market Production (K Unit), by Route of Administration, 2014 – 2024
8.7. Global Anticoagulants Drug Market Consumption (K Unit), Route of Administration, 2014 – 2024
8.8. Global Anticoagulants Drug Market Price (USD/Unit), by Route of Administration, 2014 – 2024
8.9. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Route of Administration, 2014 – 2024
9. Chapter – Global Anticoagulants Drug Market: End-User Analysis
9.1. Global Anticoagulants Drug Market Share (%), by End-User, 2014
9.2. Global Anticoagulants Drug Market Share (%), by End-User, 2017
9.3. Global Anticoagulants Drug Market Share (%), by End-User, 2024
9.4. Global Anticoagulants Drug Market Share (%), by End-User, 2017 – 2024
9.5. Global Anticoagulants Drug Market Revenue (USD Million), by End-User, 2014 – 2024
9.6. Global Anticoagulants Drug Market Production (K Unit), by End-User, 2014 – 2024
9.7. Global Anticoagulants Drug Market Consumption (K Unit), End-User, 2014 – 2024
9.8. Global Anticoagulants Drug Market Price (USD/Unit), by End-User, 2014 – 2024
9.9. Global Anticoagulants Drug Market Revenue Growth Rate (%), by End-User, 2014 – 2024
10. Chapter – Global Anticoagulants Drug Market: Manufacturer Analysis
10.1. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2014
10.2. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2017
10.3. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2024
10.4. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2017 – 2024
10.5. Global Anticoagulants Drug Market Revenue (USD Million), by Manufacturer, 2014 – 2024
10.6. Global Anticoagulants Drug Market Production (K Unit), by Manufacturer, 2014 – 2024
10.7. Global Anticoagulants Drug Market Consumption (K Unit), Manufacturer, 2014 – 2024
10.8. Global Anticoagulants Drug Market Price (USD/Unit), by Manufacturer, 2014 – 2024
10.9. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
11. Chapter – Anticoagulants Drug Market: Regional Analysis
11.1. North America
11.1.1. U.S.
11.2. Europe
11.2.1. UK
11.2.2. France
11.2.3. Germany
11.3. Asia Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.4. Latin America
11.4.1. Brazil.
11.5. Middle East & Africa
12. hapter – Company Profiles
12.1. Bayer AG
12.1.1. Overview
12.1.2. Financials
12.1.3. Product portfolio
12.1.4. Bayer AG Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.1.5. Bayer AG Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.1.6. Business strategy
12.1.7. Recent developments
12.2. Novartis AG
12.2.1. Overview
12.2.2. Financials
12.2.3. Product portfolio
12.2.4. Novartis AG, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.2.5. Novartis AG, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.2.6. Business strategy
12.2.7. Recent developments
12.3. GlaxoSmithKline plc
12.3.1. Overview
12.3.2. Financials
12.3.3. Product portfolio
12.3.4. GlaxoSmithKline plc, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.3.5. GlaxoSmithKline plc, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.3.6. Business strategy
12.3.7. Recent developments
12.4. Bristol Myers Squibb Company
12.4.1. Overview
12.4.2. Financials
12.4.3. Product portfolio
12.4.4. Bristol Myers Squibb Company, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.4.5. Bristol Myers Squibb Company, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.4.6. Business strategy
12.4.7. Recent developments
12.5. Sanofi
12.5.1. Overview
12.5.2. Financials
12.5.3. Product portfolio
12.5.4. Sanofi. Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.5.5. Sanofi. Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.5.6. Business strategy
12.5.7. Recent developments
12.6. Boehringer Ingelheim GmbH,
12.6.1. Overview
12.6.2. Financials
12.6.3. Product portfolio
12.6.4. Boehringer Ingelheim GmbH,Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.6.5. Boehringer Ingelheim GmbH,Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.6.6. Business strategy
12.6.7. Recent developments
12.7. Genentech, Inc.
12.7.1. Financials
12.7.2. Product portfolio
12.7.3. Genentech, Inc., Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.7.4. Genentech, Inc., Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.7.5. Business strategy
12.7.6. Recent developments
12.8. AstraZeneca plc
12.8.1. Overview
12.8.2. Financials
12.8.3. Product portfolio
12.8.4. AstraZeneca plc, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.8.5. AstraZeneca plc, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.8.6. Business strategy
12.8.7. Recent developments
12.9. Eli Lilly & Company
12.9.1. Overview
12.9.2. Financials
12.9.3. Product portfolio
12.9.4. Eli Lilly & Company, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
12.9.5. Eli Lilly & Company, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
12.9.6. Business strategy
12.9.7. Recent developments
List of Figure
1. Primary Research
2. Secondary Research
3. Porter’s Five Forces Analysis
4. Market attractiveness analysis by Drug Class segment
5. Market attractiveness analysis by Application segment
6. Market attractiveness analysis by Route of Administration segment
7. Market attractiveness analysis by End User segment
8. Market attractiveness analysis by regional segment
9. Global Anticoagulants Drug Market Production (K Unit) and Growth Rate (%), 2014- 2024
10. Global Anticoagulants Drug Market Consumption (K Unit) and Growth (%) Rate, 2014- 2024
11. Global Anticoagulants Drug Market Revenue (USD Million) and Growth Rate (%), 2014- 2024
12. Global Anticoagulants Drug Market Share (%) by Region, 2014 – 2024
13. Global Anticoagulants Drug Market Share (%) by Manufacturer, 2017
14. Global Anticoagulants Drug Market Share (%), by Drug Class, 2014
15. Global Anticoagulants Drug Market Share (%), by Drug Class, 2017
16. Global Anticoagulants Drug Market Share (%), by Drug Class, 2024
17. Global Anticoagulants Drug Market Share (%), by Drug Class, 2017 – 2024
18. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Drug Class, 2014 – 2024
19. Global Anticoagulants Drug Market Share (%), by Application, 2014
20. Global Anticoagulants Drug Market Share (%), by Application, 2017
21. Global Anticoagulants Drug Market Share (%), by Application, 2024
22. Global Anticoagulants Drug Market Share (%), by Application, 2017 – 2024
23. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Route of Administration, 2014 – 2024
24. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2014
25. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2017
26. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2024
27. Global Anticoagulants Drug Market Share (%), by Route of Administration, 2017 – 2024
28. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Application, 2014 – 2024 Global Anticoagulants Drug Market Share (%), by End User, 2014
29. Global Anticoagulants Drug Market Share (%), by End User, 2017
30. Global Anticoagulants Drug Market Share (%), by End User 2024
31. Global Anticoagulants Drug Market Share (%), by End User, 2017 – 2024
32. Global Anticoagulants Drug Market Revenue Growth Rate (%), by End User, 2014 – 2024
33. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2014
34. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2017
35. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2024
36. Global Anticoagulants Drug Market Share (%), by Manufacturer, 2017 – 2024
37. Global Anticoagulants Drug Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
38. North America Anticoagulants Drug Revenue Market Share (%) By Country, 2014 – 2024.
39. North America Anticoagulants Drug Revenue Market Share (%) By Drug Class, 2014 – 2024.
40. North America Anticoagulants Drug Revenue Market Share (%) By Application, 2014 – 2024.
41. North America Anticoagulants Drug Revenue Market Share (%) By Route of Administration, 2014 – 2024
42. North America Anticoagulants Drug Revenue Market Share (%) By End User, 2014 – 2024
43. North America Anticoagulants Drug Market Consumption (K Unit) and Growth Rate (%), 2014 – 2024.
44. North America Anticoagulants Drug Consumption Market Share (%) By Country, 2014 – 2024.
45. North America Anticoagulants Drug Consumption Market Share (%) By Drug Class, 2014 – 2024.
46. North America Anticoagulants Drug Consumption Market Share (%) By Application, 2014 – 2024.
47. North America Anticoagulants Drug Consumption Market Share (%) By Rout of Administration, 2014 – 2024
48. North America Anticoagulants Drug Consumption Market Share (%) By End User, 2014 – 2024
49. North America Anticoagulants Drug Production Market Share (%) By Country, 2014 – 2024.
50. North America Anticoagulants Drug Production Market Share (%) By Drug Class, 2014 – 2024.
51. North America Anticoagulants Drug Production Market Share (%) By Application, 2014 – 2024.
52. North America Anticoagulants Drug Production Market Share (%) By Route of Administration,
53. North America Anticoagulants Drug Production Market Share (%) By End User,
54. Europe Anticoagulants Drug Revenue Market Share (%) By Country, 2014 – 2024.
55. Europe Anticoagulants Drug Revenue Market Share (%) By Drug Class, 2014 – 2024.
56. Europe Anticoagulants Drug Revenue Market Share (%) By Application, 2014 – 2024.
57. Europe Anticoagulants Drug Market Consumption (K Unit) and Growth Rate (%), 2014 – 2024.
58. Europe Anticoagulants Drug Consumption Market Share (%) By Country, 2014 – 2024.
59. Europe Anticoagulants Drug Consumption Market Share (%) By Drug Class, 2014 – 2024.
60. Europe Anticoagulants Drug Consumption Market Share (%) By Application, 2014 – 2024.
61. Europe Anticoagulants Drug Revenue Market Share (%) By Route of Administration, 2014 – 2024
62. Europe Anticoagulants Drug Revenue Market Share (%) By End User, 2014 – 2024
63. Europe Anticoagulants Drug Production Market Share (%) By Country, 2014 – 2024.
64. Europe Anticoagulants Drug Production Market Share (%) By Drug Class, 2014 – 2024.
65. Europe Anticoagulants Drug Production Market Share (%) By Application, 2014 – 2024.
66. Europe Anticoagulants Drug Production Market Share (%) By Route of Administartion, 2014 – 2024.
67. Europe Anticoagulants Drug Production Market Share (%) By End User, 2014 – 2024.
68. Asia Pacific Anticoagulants Drug Revenue Market Share (%) By Country, 2014 – 2024.
69. Asia Pacific Anticoagulants Drug Revenue Market Share (%) By Drug Class, 2014 – 2024.
70. Asia Pacific Anticoagulants Drug Revenue Market Share (%) By Application, 2014 – 2024.
71. Asia Pacific Anticoagulants Drug Revenue Market Share (%) By Route of Administration, 2014 – 2024.
72. Asia Pacific Anticoagulants Drug Revenue Market Share (%) By End User, 2014 – 2024
73. Asia Pacific Anticoagulants Drug Market Consumption (K Unit) and Growth Rate (%), 2014 – 2024.
74. Asia Pacific Anticoagulants Drug Consumption Market Share (%) By Country, 2014 – 2024.
75. Asia Pacific Anticoagulants Drug Consumption Market Share (%) By Drug Class, 2014 – 2024.
76. Asia Pacific Anticoagulants Drug Consumption Market Share (%) By Application, 2014 – 2024.
77. Asia Pacific Anticoagulants Drug Consumption Market Share (%) By Route of Administration, 2014 – 2024.
78. Asia Pacific Anticoagulants Drug Consumption Market Share (%) By End User, 2014 – 2024.
79. Asia Pacific Anticoagulants Drug Production Market Share (%) By Country, 2014 – 2024.
80. Asia Pacific Anticoagulants Drug Production Market Share (%) By Drug Class, 2014 – 2024.
81. Asia Pacific Anticoagulants Drug Production Market Share (%) By Application, 2014 – 2024
82. Asia Pacific Anticoagulants Drug Production Market Share (%) By Route of Administration, 2014 – 2024.
83. Asia Pacific Anticoagulants Drug Production Market Share (%) By End User, 2014 – 2024.
84. Latin America Anticoagulants Drug Revenue Market Share (%) By Country, 2014 – 2024.
85. Latin America Anticoagulants Drug Revenue Market Share (%) By Drug Class, 2014 – 2024.
86. Latin America Anticoagulants Drug Revenue Market Share (%) By Application, 2014 – 2024.
87. Latin America Anticoagulants Drug Revenue Market Share (%) By Route of Administration, 2014 – 2024.
88. Latin America Anticoagulants Drug Revenue Market Share (%) By End User, 2014 – 2024.
89. Latin America Anticoagulants Drug Market Consumption (K Unit) and Growth Rate (%), 2014 – 2024.
90. Latin America Anticoagulants Drug Consumption Market Share (%) By Country, 2014 – 2024.
91. Latin America Anticoagulants Drug Consumption Market Share (%) By Drug Class, 2014 – 2024.
92. Latin America Anticoagulants Drug Consumption Market Share (%) By Application, 2014 – 2024.
93. Latin America Anticoagulants Drug Consumption Market Share (%) By Route of Administration, 2014 – 2024.
94. Latin America Anticoagulants Drug Consumption Market Share (%) By End User, 2014 – 2024.
95. Latin America Anticoagulants Drug Production Market Share (%) By Country, 2014 – 2024.
96. Latin America Anticoagulants Drug Production Market Share (%) By Drug Class, 2014 – 2024.
97. Latin America Anticoagulants Drug Production Market Share (%) By Application, 2014 – 2024
98. Latin America Anticoagulants Drug Production Market Share (%) By Routr of Administration, 2014 – 2024
99. Latin America Anticoagulants Drug Production Market Share (%) By End User, 2014 – 2024.
100. Middle East & Africa Anticoagulants Drug Revenue Market Share (%) By Country, 2014 – 2024.
101. Middle East & Africa Anticoagulants Drug Revenue Market Share (%) By Drug Class, 2014 – 2024.
102. Middle East & Africa Anticoagulants Drug Revenue Market Share (%) By Application, 2014 – 2024.
103. Middle East & Africa Anticoagulants Drug Revenue Market Share (%) By Route of Administration, 2014 – 2024
104. Middle East & Africa Anticoagulants Drug Revenue Market Share (%) By End User, 2014 – 2024
105. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit) and Growth Rate (%), 2014 – 2024.
106. Middle East & Africa Anticoagulants Drug Consumption Market Share (%) By Country, 2014 – 2024.
107. Middle East & Africa Anticoagulants Drug Consumption Market Share (%) By Drug Class, 2014 – 2024.
108. Middle East & Africa Anticoagulants Drug Consumption Market Share (%) By Application, 2014 – 2024.
109. Middle East & Africa Anticoagulants Drug Consumption Market Share (%) By Route of Administration, 2014 – 2024
110. Middle East & Africa Anticoagulants Drug Consumption Market Share (%) By End User, 2014 – 2024
111. Middle East & Africa Anticoagulants Drug Production Market Share (%) By Country, 2014 – 2024.
112. Middle East & Africa Anticoagulants Drug Production Market Share (%) By Drug Class, 2014 – 2024.
113. Middle East & Africa Anticoagulants Drug Production Market Share (%) By Application, 2014 – 2024.
114. Middle East & Africa Anticoagulants Drug Production Market Share (%) By Route of Administration, 2014 – 2024
115. Middle East & Africa Anticoagulants Drug Production Market Share (%) By End User, 2014 – 2024
116. Daihen Corporation, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
117. Daihen Corporation, Anticoagulants Drug Sales Market Share (%), 2014 – 2017
118. Denso Corporation, Anticoagulants Drug Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
119. Denso Corporation, Anticoagulants Drug Sales Market Share (%), 2014 – 2017

List of Figures
1. Market Drivers
2. Market Restraints
3. Market Opportunity
4. Anticoagulants Drug: Market snapshot
5. Global Anticoagulants Drug Market Revenue (USD Million), by Drug Class, 2014 – 2024
6. Global Anticoagulants Drug Market Production (K Unit), by Drug Class, 2014 – 2024
7. Global Anticoagulants Drug Market Consumption (K Unit), Drug Type, 2014 – 2024
8. Global Anticoagulants Drug Market Price (USD/Unit), by Drug Class, 2014 – 2024
9. Global Anticoagulants Drug Market Revenue (USD Million), by Application, 2014 – 2024
10. Global Anticoagulants Drug Market Production (K Unit), by Application, 2014 – 2024
11. Global Anticoagulants Drug Market Consumption (K Unit), Application, 2014 – 2024
12. Global Anticoagulants Drug Market Price (USD/Unit), by Application, 2014 – 2024
13. Global Anticoagulants Drug Market Revenue (USD Million), by Route of , 2014 – 2024
14. Global Anticoagulants Drug Market Production (K Unit), by Route of Administration, 2014 – 2024
15. Global Anticoagulants Drug Market Consumption (K Unit), Route of Administration, 2014 – 2024
16. Global Anticoagulants Drug Market Price (USD/Unit), by Route of Administration, 2014 – 2024
17. Global Anticoagulants Drug Market Revenue (USD Million), by End User, 2014 – 2024
18. Global Anticoagulants Drug Market Production (K Unit), by End User, 2014 – 2024
19. Global Anticoagulants Drug Market Consumption (K Unit), End User , 2014 – 2024
20. Global Anticoagulants Drug Market Price (USD/Unit), by End User, 2014 – 2024
21. Global Anticoagulants Drug Market Revenue (USD Million), by Manufacturer, 2014 – 2024
22. Global Anticoagulants Drug Market Production (K Unit), by Manufacturer, 2014 – 2024
23. Global Anticoagulants Drug Market Consumption (K Unit), Manufacturer, 2014 – 2024
24. North America Anticoagulants Drug Market Revenue (USD Million) By Country, 2014 – 2024.
25. North America Anticoagulants Drug Market Revenue (USD Million), By Drug Class, 2014 – 2024.
26. North America Anticoagulants Drug Market Revenue (USD Million), By Application, 2014 – 2024.
27. North America Anticoagulants Drug Market Revenue (USD Million), By Route of Administration, 2014 – 2024
28. North America Anticoagulants Drug Market Revenue (USD Million), By End User, 2014 – 2024
29. North America Anticoagulants Drug Market Consumption (K Unit) By Country, 2014 – 2024.
30. North America Anticoagulants Drug Market Consumption (K Unit), By Drug Class, 2014 – 2024.
31. North America Anticoagulants Drug Market Consumption (K Unit), By Application, 2014 – 2024.
32. North America Anticoagulants Drug Market Production (K Unit) By Country, 2014 – 2024.
33. North America Anticoagulants Drug Market Production (K Unit), By Drug Class, 2014 – 2024.
34. North America Anticoagulants Drug Market Production (K Unit), By Application, 2014 – 2024.
35. North America Anticoagulants Drug Market Production (K Unit), By Route of Administration, 2014 – 2024
36. North America Anticoagulants Drug Market Production (K Unit), By End User, 2014 – 2024
37. Europe Anticoagulants Drug Market Revenue (USD Million) By Country, 2014 – 2024.
38. Europe Anticoagulants Drug Market Revenue (USD Million), By Drug Class, 2014 – 2024.
39. Europe Anticoagulants Drug Market Revenue (USD Million), By Application, 2014 – 2024.
40. Europe Anticoagulants Drug Market Consumption (K Unit) By Country, 2014 – 2024.
41. Europe Anticoagulants Drug Market Consumption (K Unit), By Drug Class, 2014 – 2024.
42. Europe Anticoagulants Drug Market Consumption (K Unit), By Application, 2014 – 2024.
43. Europe Anticoagulants Drug Market Consumption (K Unit), By Route of Administration, 2014 – 2024
44. Europe Anticoagulants Drug Market Consumption (K Unit), By End User, 2014 – 2024
45. Europe Anticoagulants Drug Market Production (K Unit) By Country, 2014 – 2024.
46. Europe Anticoagulants Drug Market Production (K Unit), By Drug Class, 2014 – 2024.
47. Europe Anticoagulants Drug Market Production (K Unit), By Application, 2014 – 2024.
48. Europe Anticoagulants Drug Market Production (K Unit), By Route of Administration, 2014 – 2024.
49. Europe Anticoagulants Drug Market Production (K Unit), By End User, 2014 – 2024.
50. Asia Pacific Anticoagulants Drug Market Revenue (USD Million) By Country, 2014 – 2024.
51. Asia Pacific Anticoagulants Drug Market Revenue (USD Million), By Drug Class, 2014 – 2024.
52. Asia Pacific Anticoagulants Drug Market Revenue (USD Million), By Application, 2014 – 2024.
53. Asia Pacific Anticoagulants Drug Market Revenue (USD Million), By Route of Administration, 2014 – 2024.
54. Asia Pacific Anticoagulants Drug Market Revenue (USD Million), By End User, 2014 – 2024.
55. Asia Pacific Anticoagulants Drug Market Consumption (K Unit) By Country, 2014 – 2024.
56. Asia Pacific Anticoagulants Drug Market Consumption (K Unit), By Drug Class, 2014 – 2024.
57. Asia Pacific Anticoagulants Drug Market Consumption (K Unit), By Application, 2014 – 2024.
58. Asia Pacific Anticoagulants Drug Market Consumption (K Unit), By Route of Administration, 2014 – 2024.
59. Asia Pacific Anticoagulants Drug Market Consumption (K Unit), By End User, 2014 – 2024.
60. Asia Pacific Anticoagulants Drug Market Production (K Unit) By Country, 2014 – 2024.
61. Asia Pacific Anticoagulants Drug Market Production (K Unit), By Drug Class, 2014 – 2024.
62. Asia Pacific Anticoagulants Drug Market Production (K Unit), By Application, 2014 – 2024.
63. Asia Pacific Anticoagulants Drug Market Production (K Unit), By Route of Administration, 2014 – 2024
64. Asia Pacific Anticoagulants Drug Market Production (K Unit), By End User, 2014 – 2024
65. Latin America Anticoagulants Drug Market Revenue (USD Million) By Country, 2014 – 2024.
66. Latin America Anticoagulants Drug Market Revenue (USD Million), By Drug Class, 2014 – 2024.
67. Latin America Anticoagulants Drug Market Revenue (USD Million), By Application, 2014 – 2024.
68. Latin America Anticoagulants Drug Market Consumption (K Unit) By Country, 2014 – 2024.
69. Latin America Anticoagulants Drug Market Consumption (K Unit), By Drug Class, 2014 – 2024.
70. Latin America Anticoagulants Drug Market Consumption (K Unit), By Application, 2014 – 2024.
71. Latin America Anticoagulants Drug Market Consumption (K Unit), By Route of Administration, 2014 – 2024.
72. Latin America Anticoagulants Drug Market Consumption (K Unit), By End User, 2014 – 2024.
73. Latin America Anticoagulants Drug Market Production (K Unit) By Country, 2014 – 2024.
74. Latin America Anticoagulants Drug Market Production (K Unit), By Drug Class, 2014 – 2024.
75. Latin America Anticoagulants Drug Market Production (K Unit), By Application, 2014 – 2024
76. Latin America Anticoagulants Drug Market Production (K Unit), By Route of Administration, 2014 – 2024
77. Latin America Anticoagulants Drug Market Production (K Unit), By End User, 2014 – 2024.
78. Middle East & Africa Anticoagulants Drug Market Revenue (USD Million) By Country, 2014 – 2024.
79. Middle East & Africa Anticoagulants Drug Market Revenue (USD Million), By Drug Class, 2014 – 2024.
80. Middle East & Africa Anticoagulants Drug Market Revenue (USD Million), By Application, 2014 – 2024.
81. Middle East & Africa Anticoagulants Drug Market Revenue (USD Million), By Route of Administration, 2014 – 2024
82. Middle East & Africa Anticoagulants Drug Market Revenue (USD Million), By End User, 2014 – 2024
83. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit) By Country, 2014 – 2024.
84. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit), By Drug Class, 2014 – 2024.
85. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit), By Application, 2014 – 2024.
86. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit), By Route of Administration, 2014 – 2024
87. Middle East & Africa Anticoagulants Drug Market Consumption (K Unit), By End User, 2014 – 2024
88. Middle East & Africa Anticoagulants Drug Market Production (K Unit) By Country, 2014 – 2024.
89. Middle East & Africa Anticoagulants Drug Market Production (K Unit), By Drug Class, 2014 – 2024.
90. Middle East & Africa Anticoagulants Drug Market Production (K Unit), By Application, 2014 – 2024.
91. Middle East & Africa Anticoagulants Drug Market Production (K Unit), By Route of Administration, 2014 – 2024
92. Middle East & Africa Anticoagulants Drug Market Production (K Unit), By End User, 2014 – 2024

• Bayer AG
• Novartis AG
• GlaxoSmithKline plc
• Bristol Myers Squibb Company
• Sanofi
• Boehringer Ingelheim GmbH
• Genentech, Inc.
• AstraZeneca plc
• Others